Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BLND NYSE:PSN NASDAQ:TEM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLNDBlend Labs$1.53-0.3%$1.58$1.18▼$4.49$370.44M1.034.25 million shs3.15 million shsPSNParsons$51.84+0.4%$53.25$48.23▼$89.50$5.53B0.61.44 million shs556,249 shsTEMTempus AI$46.49+1.3%$49.02$41.73▼$104.32$8.24B3.996.11 million shs3.80 million shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLNDBlend Labs+2.69%+4.10%-5.57%-11.34%-57.87%PSNParsons+1.18%+2.50%-5.88%-21.64%-24.32%TEMTempus AI+0.77%0.00%-19.20%-23.48%-26.51%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLNDBlend Labs$1.53-0.3%$1.58$1.18▼$4.49$370.44M1.034.25 million shs3.15 million shsPSNParsons$51.84+0.4%$53.25$48.23▼$89.50$5.53B0.61.44 million shs556,249 shsTEMTempus AI$46.49+1.3%$49.02$41.73▼$104.32$8.24B3.996.11 million shs3.80 million shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLNDBlend Labs+2.69%+4.10%-5.57%-11.34%-57.87%PSNParsons+1.18%+2.50%-5.88%-21.64%-24.32%TEMTempus AI+0.77%0.00%-19.20%-23.48%-26.51%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLNDBlend Labs 2.43Hold$3.32117.49% UpsidePSNParsons 2.60Moderate Buy$78.1750.78% UpsideTEMTempus AI 2.50Moderate Buy$68.6447.65% UpsideCurrent Analyst Ratings BreakdownLatest PSN, AVST, BLND, and TEM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/18/2026BLNDBlend Labs Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/15/2026PSNParsons Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C) ➝ Hold (C-)5/15/2026BLNDBlend Labs Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$5.25 ➝ $4.505/11/2026TEMTempus AI HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$95.00 ➝ $64.005/8/2026BLNDBlend Labs The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$3.505/8/2026BLNDBlend Labs CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform5/8/2026BLNDBlend Labs Citizens JmpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetMarket Outperform$5.00 ➝ $4.005/8/2026BLNDBlend Labs Keefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetMarket Perform$2.25 ➝ $1.905/8/2026TEMTempus AI BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$90.00 ➝ $80.005/6/2026TEMTempus AI TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$65.00 ➝ $68.005/4/2026BLNDBlend Labs Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)(Data available from 5/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLNDBlend Labs$123.51M2.99N/AN/A($0.23) per share-6.63PSNParsons$6.36B0.87$4.10 per share12.66$25.75 per share2.01TEMTempus AI$1.27B6.56N/AN/A$2.32 per share20.04Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLNDBlend Labs-$6.80M-$0.10N/A152.50N/A-3.72%N/A-1.63%8/6/2026 (Estimated)PSNParsons$241.14M$2.0924.8115.951.643.62%11.52%5.36%8/5/2026 (Estimated)TEMTempus AI-$245.03M-$1.72N/AN/AN/A-22.20%-53.83%-11.17%N/ALatest PSN, AVST, BLND, and TEM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/5/2026Q1 2026TEMTempus AI-$0.21-$0.13+$0.08-$0.71$345.44 million$348.12 million4/29/2026Q1 2026PSNParsons$0.70$0.79+$0.09$0.49$1.50 billion$1.49 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBLNDBlend LabsN/AN/AN/AN/AN/APSNParsonsN/AN/AN/AN/AN/ATEMTempus AIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLNDBlend LabsN/A1.811.81PSNParsons0.551.751.75TEMTempus AI2.963.313.15Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLNDBlend Labs52.56%PSNParsons98.02%TEMTempus AI24.22%Insider OwnershipCompanyInsider OwnershipBLNDBlend Labs40.30%PSNParsons1.31%TEMTempus AI24.26%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLNDBlend Labs1,690242.12 million144.54 millionNot OptionablePSNParsons21,000106.98 million105.58 millionNot OptionableTEMTempus AI3,800179.57 million136.00 millionN/APSN, AVST, BLND, and TEM HeadlinesRecent News About These Companies5 Best ARK Stocks to Buy Right Now4 hours ago | insidermonkey.comTempus AI Expands Cancer Platform With Launch of ArteraAI Prostate Test For Metastatic PatientsMay 21 at 5:56 PM | finance.yahoo.comTempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical UseMay 21 at 8:30 AM | businesswire.com4 Heavily Shorted AI Stocks to Watch Right NowMay 20 at 3:13 PM | schaeffersresearch.comAssessing Tempus AI (TEM) Valuation After Recent Share Price WeaknessMay 19 at 6:00 PM | finance.yahoo.comHow beaten-down Tempus AI stock offers a lottery ticket for traders hereMay 18 at 2:57 PM | msn.comTempus AI And BMS Deepen AI Drug Development Ties As Losses PersistMay 18 at 2:57 PM | finance.yahoo.com7 Healthcare AI Stocks Under $50 With Huge Upside PotentialMay 18 at 7:35 AM | 247wallst.comTempus AI, Inc. (NASDAQ:TEM) Receives Consensus Rating of "Moderate Buy" from BrokeragesMay 15, 2026 | americanbankingnews.comTempus AI, Inc. (NASDAQ:TEM) Receives Consensus Recommendation of "Moderate Buy" from AnalystsMay 15, 2026 | marketbeat.comHere’s Why Aristotle Core Equity Fund Bets on Tempus AI (TEM), a Healthcare Technology CompanyMay 14, 2026 | insidermonkey.comTempus AI Completes Convertible Notes Offering, Retires Secured DebtMay 13, 2026 | tipranks.comBTIG Sticks to Their Buy Rating for Tempus AI, Inc. Class A (TEM)May 12, 2026 | theglobeandmail.comIs Tempus AI (TEM) The Best AI Healthcare Stock to Buy?May 10, 2026 | finance.yahoo.comCathie Wood invests $14.9M in Tempus AI after earnings beatMay 10, 2026 | msn.comTempus AI Expands Beyond Oncology With New Alzheimer’s Blood Test AllianceMay 10, 2026 | finance.yahoo.comCathie Wood buys $14.9 million of Tempus AI stockMay 8, 2026 | msn.comTempus AI (NASDAQ:TEM) Price Target Cut to $80.00 by Analysts at BTIG ResearchMay 8, 2026 | marketbeat.comTempus AI: My Pick For An Oncoming Boom In Demand For Data-Driven Precision MedicineMay 8, 2026 | seekingalpha.comTempus AI and Scorpio Tankers expand convertible note offeringsMay 8, 2026 | msn.comTempus Announces Pricing of Upsized Offering of $400.0 Million of Convertible Senior NotesMay 7, 2026 | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePSN, AVST, BLND, and TEM Company DescriptionsBlend Labs NYSE:BLND$1.52 -0.01 (-0.33%) Closing price 03:59 PM EasternExtended Trading$1.52 0.00 (0.00%) As of 07:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Blend Labs, Inc. engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty. It also offers verification components to automate confirmation tasks that are needed to underwrite a loan or approve the opening of a new deposit account; decisioning components to reduce the need for human intervention by automatically applying business rules throughout an application workflow configured by a financial services firm; workflow intelligence components to manage data collection and automate tasks throughout the loan origination process; and marketplace components to enable consumers to shop for products and services presented at the precise moment of need during an application for a loan. In addition, the company, through its subsidiary, offers title search procedures for title insurance policies, escrow, and other closing and settlement services, as well as other trustee services; and provides professional and consulting services. It serves banks, credit unions, fintechs, and non-bank mortgage lenders. The company was incorporated in 2012 and is headquartered in San Francisco, California.Parsons NYSE:PSN$51.84 +0.19 (+0.37%) Closing price 03:59 PM EasternExtended Trading$51.74 -0.11 (-0.21%) As of 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Parsons Corporation provides integrated solutions and services in the defense, intelligence, and critical infrastructure markets in North America, the Middle East, and internationally. The company operates through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment provides critical technologies, such as cybersecurity; missile defense; intelligence; space launch and ground systems; space and weapon system resiliency; geospatial intelligence; signals intelligence; environmental remediation; border security, critical infrastructure protection; counter unmanned air systems; biometrics and bio surveillance solutions to U.S. Department of Defense, including military services; Missile Defense Agency, the Department of Energy; the Department of State; the Department of Homeland Security, and the Federal Aviation Administration. The Critical Infrastructure segment provides management, design, and engineering services, as well as offers leveraging sensor solutions. This segment develops digital solutions for next generation aviation, rail and transit, bridges, roads, and highways; and provides water and wastewater treatment systems; AI/ML, and digital twin and cyber systems integration services; planning, engineering, and management services for infrastructure, including bridges and tunnels, roads and highways, water and wastewater, and dams and reservoirs. Parsons Corporation was founded in 1944 and is headquartered in Chantilly, Virginia.Tempus AI NASDAQ:TEM$46.49 +0.61 (+1.33%) Closing price 04:00 PM EasternExtended Trading$46.50 +0.02 (+0.03%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending Target Shows Strengths, But Analysts Want to See More Freight Boom: The Hormuz Blockade Payday TJX Companies Fires on All Cylinders With 9% Revenue Growth Analog Devices Provides Much-Needed Pullback: How Low Can It Go? USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 Outlook Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
